SECONDHAND SMOKE STUDIES: .
.   THE HYPE AND THE DECEIT



 

 
 
 
 
 
 
First, we shall present the article and/or study that has been submitted which fosters self-serving jubilation in the anti-smoking community.

Following this we will proceed to shed light on the inaccuracies and meaningless results of the studies.

"Secondhand smoke kills, according to a new study!," is frantically shouted from the bold type headlines of newspapers and magazine articles. Mostly it is uneducated and/or issue biased newspaper reporters who add the hype to the already deceitful study. Either they don't bother to read the study for themselves (or they do and don't understand the scientific implications), relying on misleading statements from the researchers themselves, or they are far more interested in the fear mongering factor that makes for good reading and do not bother to check with anyone how accurate or reliable a study is. Not to mention it is more politically correct to nod their head yes and insert their own views and conclusions based on the scary sounding research title and bits of information that they have heard.

Whether it is a reporter with no concept of what it is they are actually reporting, simply relaying the study du jour, or a health organization or researcher submitting a report, none of what they say can be taken at face value.  News reports are manipulated and then hyped, as are practically all of the studies on secondhand smoke. Smokers or non-smokers who want to see accurate scientific data on the issue of tobacco smoke are not going to get it from the media, politicians or public health officials. 
 
 
 
 

Here we will look at the current secondhand smoke releases and discuss the junk science, the media lies and omissions and the research manipulation and press releases intended to attain more support for their smoke-free agenda. 
 
 






DISCUSSIONS:

Globe and Mail Article, July 12, 2001 - Secondhand smoke can triple risk of 
    lung cancer

The Centers for Disease Control, March 21, 2001 - National Report on Human
    Exposure to Environmental Chemicals

Associated Press, July 24, 2001 - Study Finds Even Limited Exposure to
    Secondhand Smoke Can Harm Arteries

National Post OnLine, February 21, 2002 - Second-hand smoke linked to crib
   death, report shows

PRNewswire, June 19, 2002 - IARC Monographs Programme Declares
    Second-Hand Tobacco Smoke Carcinogenic To Humans

Associated Press, July 31, 2002 - Researcher hoping for big changes from 
    study tying second-hand smoke to feline lymphoma

United Press International, March 11, 2003 - Smoking linked to cavities in
    kids

WebMD, April 1, 2003 - Smoking Ban Saves Lives in Montana Town

BBC News, February 11, 2004 - Smoking 'a blight on fertility'

Circulation, May 2005 - Cardiovascular Effects of Secondhand Smoke 
Nearly as Large as Smoking 
 


 
 


 
 


Secondhand smoke can triple risk of lung cancer



 
 

Secondhand smoke can triple risk of lung cancer

 by ANDRÉ PICARD / PUBLIC HEALTH REPORTER
 Source: Globe and Mail, July 12, 2001 Region: CANADA

People who are routinely exposed to a lot of secondhand smoke, such as workers in bars and restaurants, can see their risk of lung cancer triple, a new study says. The Canadian study provides some of the most compelling scientific evidence yet for a total ban on workplace smoking, including bars and restaurants.
The research, published in the International Journal of Cancer, found that the greater the amount of smoke in a workplace, the greater the risks. "These data absolutely back a smoking ban in all workplaces, including bars," said Dr. Kenneth Johnson, senior epidemiologist at the surveillance and risk-assessment division of Health Canada and the lead researcher.

Dr. Roberta Ferrence, director of the Ontario Tobacco Research Unit, said, "What's important about this research is it demonstrates a dose-response: The more exposure you have, the higher your risk. "While this may seem obvious, it has long been contested by the tobacco industry." Dr. Ferrence said she hopes that this "strong new evidence will prompt strong new action" to expand smokefree workplace laws.

"There's an underlying [belief] that secondhand smoke increases your risk of developing lung cancer by 20-25 per cent, and maybe that can be explained away by publication bias," Dr. Johnson said. "But when you see the risk rising by 75 per cent right up to a tripling of the risk, it's hard to argue that nothing is going on."
The new research found that when the number of "occupational smoker years" (the number of smokers in the workplace multiplied by the worker's years of service) reaches 26, the risk of lung cancer has doubled. (That could mean two smoking co-workers over 13 years or five smoking co-workers over five years. It could also mean 26 customers daily for a year in a bar.) When researchers looked at the upper third of workers -- those exposed to the most secondhand smoke -- they found the lung cancer risk was more than tripled.
Since the early 1980s, more than three dozen studies have examined the impact of secondhand smoke on non-smokers, but the Health Canada research is the first original Canadian data.
In the International Journal of Cancer, Dr. Johnson wrote that it is not surprising to see higher risks associated with workplace exposure because studies have consistently demonstrated that the intensity of exposure is higher on the job than at home. The level of nicotine in the air of bars is up to 15 times higher than in the home of a smoker.
Discussion on this article to be followed by the actual study abstract:

The author of this article, Mr. Picard, seems to have missed or intentionally has failed to include the following statement from the study:

"Although more years of and more intense residential passive smoke exposure tended to be associated with higher risk estimates, no clear dose-response relationship was evident."

Mr. Picard, supposedly a qualified Health Reporter, added, "[the study] provides some of the most compelling scientific evidence yet for a total ban on workplace smoking, including bars and restaurants.”

It does?  THE most compelling evidence? On the contrary, not one of the findings presented in this study reached statistical significance. Including the “dose-response” findings (increased risk with increased exposure). In fact, one of the tables shows that the risk DECREASED with increased exposure.

How would Picard explain that?

For further discussion pertaining to this article, Martha Perske, known for her meticulous and exacting work uncovering the corruption of scientific and statistical data by anti-smoking funds-motivated scientists and institutions, adds her astonishment and keen-eyed observations in the SpeakEasyForum.
 
 
She continues to take another reporter to task for his rendition of this study in the Chattanooga (TN) Times & Free Press:

Dear Edward Colby:

Lesson No. 1 in reporting on a study is that you give all relevant data, which you failed do in the case of the Canadian study.  I refer to your article, “Study finds more evidence of secondhand smoke harm,” published in the Chattanooga (TN) Times & Free Press, July 18, 2001. 

Your alarmist claim that the lung cancer risk for nonsmokers working with smokers “climbs steadily over time and increases based on the number of smokers in the workplace” is not supported by some of the results in Table III of the Canadian study.  Contrary to your claim, results presented in Table III show that the risk for those exposed to the MOST secondhand smoke in the workplace (64 or more smoker years) is LESS than for those exposed to 26-64 smoker years.  The odds ratio for exposure to 26-64 smoker years is 1.98 – but for 64 or more smoker years it drops to 1.58.

Why did you not mention that?

Again, contrary to your claim that the risk increases with increased exposure, this study shows a consistent DECREASE in risk with increased exposure for nonsmokers living and working with smokers.  It’s right there, plain as day, if you had bothered to look.   The odds ratios for nonsmokers living and working with smokers for 1-24 years, 25-45 years, and 46 or more years are, respectively, 1.46, 1.40, and 1.35.

Surely, such a decreased risk with increased exposure is newsworthy, but not one word from you about it.

Likewise, not one word from you about the study authors’ cautionary statement that the small number of cases in this study “precludes drawing strong conclusions.”

In fact, Mr. Colby, not one of the findings reported in this study is statistically significant.

The fact that you did not report all relevant data from this study is being widely circulated via the Internet.  It falls under the category of biased and sloppy reporting and does not speak well for you or your newspaper. 


 
 

It's time now to take a look at the actual abstract of the study which either Picard did not do or simply decided to pull a fast one on the public:

Epidemiology and Cancer Prevention
Lifetime residential and workplace exposure to environmental tobacco smoke and lung cancer in never-smoking women, Canada 1994-97 

Abstract

Although the risk of lung cancer among never-smokers living with a spouse who smokes has been extensively studied, the impact of lifetime residential and workplace environmental tobacco smoke has received less attention. As part of a large population-based case-control study of lung cancer, we collected lifetime residential and occupational passive smoking information from 71 women with lung cancer and 761 healthy control subjects, all of whom reported being lifetime
nonsmokers. The adjusted odds ratio (OR) for lung cancer associated with residential passive exposure only was 1.21 (95% confidence interval [CI] 0.5-2.8). Although more years of and more intense residential passive smoke exposure tended to be associated with higher risk estimates, no clear dose-response relationship was evident. The OR for women with passive
exposure as a child and as an adult was 1.63 (95% CI 0.8-3.5) and for those only exposed as an adult 1.20 (95%CI 0.5-3.0). Exposure to environmental tobacco smoke only in the workplace was associated with an adjusted OR of 1.27 (95% CI 0.4-4.0). Risks associated with increasing occupational exposure year tertiles were 1.24, 1.71 and 1.71. Total smoker-years of residential and occupational exposure combined resulted in a statistically significant trend (linear test for trend p = 0.05) with ORs for tertiles of exposure of 0.83, 1.54 and 1.82. Our results are consistent with the literature suggesting that long-term, regular exposure to either residential or occupational environmental tobacco smoke is associated with increased lung cancer risk in never-smoking women. © 2001 Wiley-Liss, Inc.
 

Received: 27 December 2000; Revised: 2 April 2001; Accepted: 4 April 2001
 

Discussion:

Rather than bore you with an essay-like response to this paper, which can lead to a loss of interest, we take you behind the scenes of a real life debate between those who are extremely knowledgeable in the science of epidemiology and those who question their findings and educated opinions.  They proceed to debunk this study posthaste because it is just that bad.  We follow up with another critique by Martha Perske.

Mr. Lauren Colby, an attorney and author of In Defense of Smokers, has studied the tobacco issue, including secondhand smoke studies, intensely for many years.  He is quite qualified to carry on this debate as are some others who have taken the time to become educated in the field of epidemiology and the application of scientific standards.

*This is a colorful insight as to how bias turns so many deaf and blind to the facts:

            Legend
Anti-Smoker
Smokers' Rights Advocate

 
Lillith:
 [saying nothing posts Globe And Mail article for review]
Jlfork:
 The confidence intervals all straddle 1.0, which means those claims are NOT
statistically significant. The study proved NOTHING. Any
claim after this point is a display of incredible chutzpah.

You don't have to believe me. Go ask a statistician. 

Paul Smith: Sorry, Fork.  Everyone is entitled to an opinion.  Frankly, I'll take the
IJC's word for it.

Believe me, I don't believe you.  Do you wonder why?

Jlfork: Because you're a fanatic, I guess.
I'd think that you'd at least want to find out what a confidence interval is.
Look it up - it won't take long. When dealing with odds ratios (ORs), the magic
number is 1.0, the null hypothesis (i.e., no effect). If you can get your CI
completely above 1.0, you have at least a claim on the effect (although many
other factors come into that assessment). If the interval is completely below
1.0, you have an inverse correlation (with the same qualifications). But if the
interval straddles (or even includes) 1.0, you have squat. That's officially
called "not significant." This is common for small sample size, which even the
study authors admitted to. And to claim an upper bound of a CI as the figure of
merit is either ignorance or deliberate deceit.  (There's another problem with
retrospective studies and recall bias, particularly when both researchers and
subjects are eager to cast blame, but we don't have to go that far to dismiss
these results.)
Like I said, go ask a statistician. Call an instructor at a local college. Go
ahead - I dare you.
Larry Colby:  Furthermore, this was a retrospective study. 71 never smoking women with lung
cancer and 761 healthy, never smoking controls were asked to remember the extent
of their exposure to second hand smoke. Such studies ALWAYS introduce recall
bias: the tendency of the lung cancer victims to "remember" (or think that they
remember) more exposure to smoke than is remembered by the controls.

At the time of the 1964 Surgeon General's Report, the SG's Committee vowed not
to use retrospective studies because of the element of recall bias (although,
perhaps inadvertently, they wound up using quite a bit of retrospective data).

Given the well known and long recognized problems with these retrospective
studies, it's surprising that any reputable scientist would take them seriously.
But this study was funded by the Canadian government, which has an anti-smoking
bias (see Chapter 6 of my book, on the "LaLonde effect"). They don't care if the
study is accurate, so long as it scares people into quitting smoking.It isn't necessary that studies prove or disprove anything. 

Paul Smith: Studies support or reject a hypothesis or theory.  This study supports the theory that ETS
is a causative factor for Lung Cancer and that makes it a worthwhile study.
Larry Colby: The study supports nothing of the kind. At most, it demonstrates that lung
cancer victims will remember or think that they remember more exposure to second
hand smoke than people who are not lung cancer victims. That's called "recall
bias" and is the reason why retrospective studies of this sort are worthless.
Paul Smith: Worthless to who?  Somebody funded the study and found the results useful
enough to publish.  While it proves nothing, it does support the growing
body of evidence that ETS is harmful.  Smokers bitch about the uselessness
or the inaccuracy or the poor design of studies and point out their
deficiencies but studies continue to be done and they continue to support
the need for a ban on ETS.
Larry Colby: The only way to remove recall bias is to conduct a prospective study over a
period of many years, repeatedly interviewing the participants to determine
their current exposure to primary or secondary smoke, and keeping track of the
number of lung cancer cases that occur. Doll started out to do something like
that with his study of British doctors, but his study was thrown off track when,
in the first few years of the study, practically all of the doctors quit smoking
cigarettes.
Paul Smith:  As I recall, the study indicated that, even taking such confounders into
consideration, the study still implicated ETS.  Not scientific proof but it
goes to the preponderance of the evidence overall.
Larry Colby: With all due respect, there is no way in the world to "correct" for recall bias!
Even if you were studying primary smokers, you'd have to establish a baseline by
studying the actual smoking habits of the smokers for many, many years, and then
finding out how much those who fell victim to lung cancer exaggerated, upon
recollection, the amount that they had actually smoked. The same would be true
of those exposed to passive smoke, but in that case, the problem is even more
formidable because you are dealing with somebody's recollection of somebody
else's smoking habits, over a period of many years.

It's totally impossible, which is why retrospective studies are worthless.

Paul Smith: I'm so sorry, Larry.  You are obviously correct.  You do, of course, know
better than the experts, the scientists doing the studies.  I'm sure that
the readership has noted your expertise and will ignore everything science
and medicine says from now on.
Larry Colby: Just because somebody has a PH.D. attached to his name doesn't mean that he
can't make mistakes. Doing a study based upon recall bias is a mistake.
Paul Smith: If so, I cannot fathom that the study would have been frowned upon by
his/her peers and roundly chastised.  Certainly it wouldn't get published.
Son of a gun, that doesn't seem to have happened.
Alex: You are singularly naive about the realities of acedemia.
Any study which appears to confirm current thinking and theories will
pass peer review.  Nor is the purpose of peer review to determine the
correctness of the results presented in the stuides, but merely to ensure
that certain guidelines for scientific procedure have been followed.
IOW, as long as the formalities have been satisfied, any study could have
been written by the researcher's dog and it would be passed.
Paul Smith: Oh, you're absolutely correct, Alex.  The studies were a waste of time and
simply put food on the table and clothes on the back of scientists'
families.  How silly of me to have missed that.  You are such a smart man, I
should have known better to take the scientific word over yours.
Larry Colby: These Canadian studies are an example of the LaLonde effect. Marc LaLonde was
formerly the Canadian Minister of National Health and Welfare. He argued that
health messages should be vigorously disseminated, and should be "loud, clear
and unequivocal", even if unsupported by scientific evidence. If a particular
study showed that smoking might be related to a particular disease, it made no
difference to him whether the study was seriously flawed, or not. He felt that
releasing the study was always justified, if it would convince people to stop
smoking, since everybody knew that smoking was unhealthy.
Paul Smith: There is a HUGE difference between science and politics.  If a politician
wants to tout bad science, he flirts with the likes of you who just love to
very publically prove them wrong but they will do it because the ends
justify the means.  For a scientist to publish tripe to his peers, however,
is suicide.
Larry Colby: Tripe gets published all the time! Auerbach got his experiment on the beagles
(in which he "sort of" claimed to have induced lung cancer in the dogs by
training them to smoke through tracheotomies) published in a scientific journal,
but, in 40 years, nobody has ever been able to duplicate his results. The cold
fusion experiments were published in a scientific journal, but nobody has been
able to duplicate them, either.  The studies that resulted in a ban on DDT were
published in scientific journals but many scientists now believe that the
studies were flawed. The journals are full of studies by scientists who believe
in global warming and others who don't.

*Source of Dialogue:  alt.smokers Newsgroup

Again, to sew things up, we present Martha Perske with a rough draft analysis of the study:

"The results (odds ratios) presented in the Abstract are not statistically significant.

"In every single case, the LOWER number of the confidence interval is below 1.0.

"For example, the odds ratio of 1.21 (a 21% increased risk) from exposure to ETS in the home is followed by a confidence interval of 0.5 to 2.8. Since the lower number (0.5) is below 1.0, this means the finding was not statistically significant.

"Only when BOTH numbers of the confidence interval are above 1.0 is it statistically significant. For example, a confidence interval of 1.5 to 2.8 would be statistically significant.

"Not one of the findings presented in this study reached statistical significance. Including the “dose-response” findings (increased risk with increased exposure). In fact, one of the tables shows that the risk DECREASED with increased exposure.

"Plus, the entire study was based on only 71 cases of nonsmokers with lung cancer. When findings were broken down into subsets the number was even smaller, in some cases only 7.

"Picard [Globe article author] claims “The new research found that when the number of ‘occupational smoker years'...reaches 26, the risk of lung cancer has doubled...When researchers looked at the upper third of workers – those exposed to the most second-hand smoke – they found the lung cancer risk was more than tripled.”

"Okay. So I go to Table III of the study where results are given for 'occupational smoker years' which Picard referred to. Results are given in terms of odds ratios.

"Well, here’s what I find: First off, not one of the increased risks (odds ratios) is statistically significant.

"Second, the odds ratios show a most implausible thing - the reported risk for exposure to 64 or more occupational smoker years was LESS than exposure to 26-64 years.

"Here are the results as reported in the study:

                    Exposure to 1-25 smoker years: Odds ratio 1.16 (based on 10 cases)
                    Exposure to 26-64 smoker years: Odds ratio 1.98 (based on 14 cases)
                    Exposure to 64 or more smoker years: Odds ratio 1.58 (based on 14 cases)

                    (“Occupational smoker years” is defined as the number of employees who smoked
                    regularly in the subject’s immediate work area multiplied by the number of years the
                    subject worked at that job. In other words, if the subject worked with 5 smokers for 10
                    years it would be 50 smoker years.)"

Read more from Martha Perske in her ongoing struggle to obtain a response from the Globe & Mail regarding their unprofessional reporting.  Her subsequent correspondence can be read at JunkScience.com
 
 
 
 

WE CONTINUE WITH...



 
National Report on Human Exposure to Environmental Chemicals

 
**PRESS RELEASE**
March 21, 2001
National Report on Human Exposure to Environmental Chemicals

New CDC Chemical Exposure Report Begins to Fill Critical
Information Gaps in Environmental Health for the U.S.
Population

            Data Show Exposure to Environmental Tobacco Smoke Down
                    Dramatically and Levels of Blood Lead Continuing to Decline 

                    The Centers for Disease Control and Prevention (CDC) today
                    released the first National Report on Human Exposure to
                    Environmental Chemicals, an important new research tool that will
                    provide better information on levels of exposure to environmental
                    chemicals, and, over time, what these levels mean for public health

                    Advances in a technology known as biomonitoring allow CDC to
                    measure chemicals directly in blood and urine samples rather than
                    to estimate population exposures by measuring air, water, or soil
                    samples. On the basis of this scientific advancement, the new
                    report provides data on actual levels of chemicals in humans. As
                    data are collected over the years, researchers will be better able
                    to determine possible health effects and design appropriate public
                    health strategies.

                    "This new resource is a significant development in the field of
                    environmental health," said Health and Human Services Secretary
                    Tommy G. Thompson. "It will help us to better track the exposures
                    of Americans to chemicals in the environment and to measure the
                    effectiveness of our public health efforts."

                    This first Report initially measures the exposure of the U.S.
                    population to 27 environmental chemicals. The Report includes
                    metals (e.g., lead and mercury), pesticide metabolites, phthalate
                    metabolites, and cotinine (which tracks exposure to tobacco
                    smoke). Levels of environmental chemicals were measured in blood
                    and urine samples collected from participants in CDC's National
                    Health and Nutrition Examination Survey (NHANES) ---  an ongoing
                    national health survey of the U.S. population. The Report provides
                    results from the 1999 survey; data from future years will help
                    confirm these findings. 

                    "The Report is a major step toward assessing in the U.S. population
                    which environmental chemicals are present in blood and urine
                    samples, who is exposed, trends in exposure over time, and
                    whether interventions to reduce exposure are working," said
                    Richard J. Jackson, MD, MPH, Director of CDC's National Center for
                    Environmental Health (NCEH). 

                    Although the report does not include new information on health
                    risks of exposures or on potential routes of exposures, this is the
                    first time that national exposure levels of the U.S. population are
                    known for 24 of these 27 chemicals. CDC previously assessed the
                    population's exposure to three substances --- lead, cadmium, and
                    cotinine. The Report provides new data for the 1999 calendar year.
                    Previously, only limited data were available on which environmental
                    chemicals were in the U.S. population and at what levels. 

                    The presence of a chemical in blood or urine does not necessarily
                    indicate that the chemical will cause disease. Additional research is
                    required to determine whether the levels reported are a cause for
                    health concern.

                   The first Report provides information on the exposure of the U.S.
                    population to these 27 chemicals. The chemicals, grouped into four
                    categories, are as follows: 

                         Metals: lead, mercury, cadmium, cobalt, antimony, barium,
                         beryllium, cesium, molybdenum, platinum, thallium, tungsten,
                         and uranium.
                         Tobacco smoke: cotinine --- a metabolite of nicotine that
                         tracks tobacco smoke exposure.
                         Organophosphate pesticides (Six metabolite
                         measurements representing exposure to 28 pesticides):
                         dimethylphosphate, dimethylthiophosphate,
                         dimethyldithiophosphate, diethylphosphate,
                         diethylthiophosphate, and diethyldithiophosphate. These
                         metabolites are generally formed by the breakdown of 28
                         pesticides, including chlorpyrifos, diazinon, fenthion,
                         malathion, parathion, disulfoton, phosmet, phorate,
                         temephos, and methyl parathion.
                          Phthalate metabolites: mono-ethyl phthalate, mono-butyl
                         phthalate, mono-2-ethylhexyl phthalate, mono-cyclohexyl
                         phthalate, mono-n-octyl phthalate, mono-isononyl phthalate,
                         and mono-benzyl phthalate.

                    Highlights of the Report

                    Cotinine
                    Cotinine is a breakdown product of nicotine after it enters the
                    body. Levels of cotinine in the body track the amount of exposure
                    a person has to tobacco smoke. For a nonsmoker, cotinine tracks
                    exposure to environmental tobacco smoke. CDC measured cotinine
                    in nonsmokers in the U.S. population as part of a previous survey,
                    and the Report presents new cotinine data for 1999. 

                    “One significant finding was the more than 75% decrease in serum
                    cotinine levels for nonsmokers in the United States," said Jim Pirkle
                    MD, PhD, of CDC’s Environmental Laboratory and coauthor of the
                    Report. “This decrease documents a dramatic reduction in exposure
                    of the U.S. population to environmental tobacco smoke since 1991.
                    However, environmental tobacco smoke remains a major public
                    health concern since more than half of American youth continue to
                    be exposed to this known human carcinogen.”

                    Lead
                    CDC has been measuring the population’s exposure to lead since
                    1976 through the NHANES surveys. CDC’s Childhood Lead Poisoning
                    Prevention Program (www.cdc.gov/nceh/lead/lead.htm) works to
                    reduce exposure of children in the United States to lead. The
                    Report presents measurements of levels of lead in blood for U.S.
                    children in 1999. 

                    “The good news is that blood lead levels continue to decline among
                    children overall,” said Eric Sampson, PhD, of CDC’s Environmental
                    Laboratory and also a coauthor of the Report.  “However, other
                    data show that children living in environments placing them at high
                    risk for lead exposure remain a major public health concern.”

                    Next Steps 
                    Environmental health is one of the "Leading Health Indicators" in
                    the U.S. government publication,  Healthy People 2010. Information
                    on environmental chemical exposures will assist clinicians and public
                    health officials to better understand the relationship between toxic
                    exposures and health consequences and will help guide public
                    health prevention efforts. CDC will add other substances to future
                    reports on the basis of data obtained from samples collected in
                    subsequent NHANES surveys. CDC will continue to measure the 27
                    original substances as well. The goal over the next few years is to
                    expand the Report to provide information about 100 chemicals. CDC
                    will monitor trends over time that may help scientists better
                    understand the impact of environmental chemicals on our health. In
                    the future, CDC will be able to report exposure levels for more
                    specific population groups (e.g., children, minority populations, or
                    women of childbearing age). 

                    In addition, CDC will expand the Report to include exposure data
                    from studies of people exposed from localized or point-source
                    exposures (e.g., data on levels of mercury in people who eat
                    mercury-contaminated fish from a polluted river). For more
                    information on the Report data, log onto
                    www.cdc.gov/nceh/dls/report or call 1-866-670-6052.

                    CDC protects people’s health and safety by preventing and
                    controlling diseases and injuries; enhances health decisions by
                    providing credible information on critical health issues; and
                    promotes healthy living through strong partnerships with local,
                    national, and international organizations. 

Discussion on this article:  NONE  All discussion to follow STUDY ABSTRACT
CDC ABSTRACT on Findings of Exposure to Cotinine:
 
Major Findings
Highlights

Reduced Exposure of the U.S. Population to Environmental
Tobacco Smoke

                    Cotinine is a metabolite of nicotine that tracks exposure to
                    environmental tobacco smoke (ETS) among nonsmokers; higher
                    cotinine levels reflect more exposure to ETS. ETS has been
                    identified as a known human carcinogen. From 1988 through 1991,
                    as part of the NHANES III survey, CDC determined that the median
                    level (50th percentile) of cotinine among nonsmokers in the United
                    States was 0.20 nanograms per milliliter (ng/mL).  Results from the
                    1999 Report showed that the median cotinine level among people
                    aged 3 years and older has decreased to less than 0.050
                    ng/mL-more than a 75% decrease. This reduction in cotinine levels
                    objectively documents a dramatic reduction in exposure of the
                    general U.S. population to environmental tobacco smoke since the
                    period 1988-1991.  However, since more than half of American
                   youth are still exposed, ETS remains a major public health concern.
 

The Report--Major Findings 
           The Report-- Overview
           The Report-- Results 
           The Report Summary (a PDF file)
           The Complete Report (a PDF file)
           The Frequently asked Questions (FAQs)
           Related Links
 

Discussion:  QUESTION - Do the ends justify the effort?

The Centers for Disease Control released the first National Report on Human Exposure to Environmental Chemicals. In a Press Release dated March 21, 2001 they chirped about their new project to measure the amount of 27 chemicals in urine and blood, "a new research tool that will provide better information on levels of exposure to environmental chemicals, and, over time, what these levels mean for public health."

They go on to report a 75% decrease in cotinine levels (a metabolite of nicotine that tracks tobacco smoke exposure).  Judging from the following statement, we can only assume that they are comparing 1999 to 1991, "This decrease documents a dramatic reduction in exposure of the U.S. population to environmental tobacco smoke since 1991."  Well, sure there is a decrease.  In 1991 people were still smoking in their workplace and in most restaurants.  People were still smoking practically everywhere before the health fanatics put an end to that with smoking bans almost everywhere sometime around 1995.  Big surprise!  What on earth are they crowing about?  How to waste our money on silly reports?

One wonders though how they know what the decrease is if they are using random subjects.  Wouldn't it be more substantial if they assessed the same people each time?

Aside from any argument about how much smoking is actually occuring in public areas, the more important questions related to this decrease is how substantial was the exposure prior to reporting a decrease and, once that is understood, what are they actually trying to accomplish by studying this chemical exposure?

Included in their Press Release is the most telling statement of all:

"The presence of a chemical in blood or urine does not necessarily indicate that the chemical will cause disease. Additional research is required to determine whether the levels reported are a cause for health concern."

Now that we finally have it...  that the mere presence of a chemical does not automatically lead to illness, one must also note that not only is that true, but it is a huge understatement in regard to their cotinine measurements:

"From 1988 through 1991, as part of the NHANES III survey, CDC determined that the median level (50th percentile) of cotinine among nonsmokers in the United States was 0.20 nanograms per milliliter (ng/mL).  Results from the 1999 Report showed that the median cotinine level among people aged 3 years and older has decreased to less than 0.050 ng/mL-more than a 75% decrease."

NANOGRAMS!!  Not even a whole nanogram which means they're avoiding using the term PICOGRAM!

Most people are not familiar with these terms in weight and where they fall on the scale.  Here is a weight chart in order to make more sense of just where these weights fall in the grand scheme of things:

          1 gram (g) = 1000 milligrams (mg)
          1 milligram (mg) = 1000 microgram (ug)
          1 microgram (ug) = 1000 nanogram (ng)
          1 nanogram (ng) = 1000 picogram (pg)

To further enhance some visual aid you might require to fathom these measurements, picture a grain of salt.

A grain of salt weighs 100,000 nanograms or 100,000,000 picograms.

We'll proceed to make some conversions in order to bring the full picture into view (keep in mind that we are using their own figures that cotinine levels among nonsmokers in the United States is now 0.05 nanograms per milliliter):

1.  We needed  to convert their decimalized nanograms ( into picograms) (which is really what it is) and did the following:

     One twentieth (.05) of a nanogram (one nanogram being equal to 1000 picograms) is 50 picograms
     [formula: 1000/20=50]

2.  The average weight of a grain of salt is 0.10mg or 0.00010g. (It may vary a little but not enough to make much of a difference when considering such infintismal weights).

Then we had to convert the milligrams into picograms (with the help of the conversion chart):

      One tenth (0.10) of a milligram (one milligram being equal to1000 micrograms) is 100 micrograms.
      [formula: 1000/10=100]

      100 micrograms (a microgram being equal to 1000 nanograms) is100,000 nanograms
      [formula: 100*1000=100,000]

      100,000 nanograms (one nanogram being equal to 1000 picograms) is 100,000,000 picograms
      [formula: 100,000*1000=100,000,000]

Ergo a grain of salt weighs 100,000 nanograms or 100,000,000 picograms.

3.  Next, the study uses milliliters of blood instead of liters ("nanograms per milliliters").  The normal human adult has approximately 5-6 liters of blood in his body.

Since the study is talking more about kids we went with the lower end of 5 and calculated this:

      1 liter = 1000 milliliters
      5 liters x 1000 milliliters = 5000 milliliters

4.  Before reaching the finish line, I wanted to confirm their "75% decrease":

      200 picograms (.20 nanograms) to 50 picograms (.05 nanograms) = difference of 150 which is 75% of 200

5.  We can finally figure out how many nanograms/picograms per entire human blood supply they're really talking about in their given study:

      .05 nanograms x 5000 milliliters = 250 nanograms or 250,000 picograms (End result of their equation of
     .05ng/mL)

Our final argument?

That on average, a grain of salt weighs 100,000 nanograms (returning to the larger weight unit).

Their study concludes that the body takes in 250 nanograms of cotinine in comparison.

How ridiculous is that miniscule amount to consider as having a "harmful effect?"

More importantly, before they even saw a reduction of 75%, consider this.  Did .20 nanograms of cotinine in a person's system mean anything of concern to begin with?  That would be 1000 nanograms.
99,000 nanograms less than a grain of salt!

Be especially aware of this trick when you hear a report claiming an increase and the scream, "Something must be done!"  It's just as unmeaningful as it is the other way around.

If only they would adhere to their own scientific standards when it comes to the issue of secondhand smoke, we wouldn't be bombarded with meaningless studies and unnecessary projects that waste the taxpayers' money in order to inflict their version of correct behavior on the unwitting public:
 
 

American Council on Science and Health (ACSH)
http://www.acsh.org/publications/booklets/traceChem.html
"The presence in the body of a trace chemical generally signifies occupational or lifestyle-related exposure to that substance. Such a presence alone should not be overinterpreted as necessarily injurious to health, however. For the vast majority of exogenous chemicals (chemicals originating outside the body), there is no evidence to suggest that trace concentrations in the body present a risk to human health."

And for those who scoff at the argument that if ETS is so dangerous then smokers, who are not only exposing themselves to mainstream smoke (directly inhaled) but also to their sidestream smoke should be dropping dead at a greater rate than currently calculated, need to take into account that if the measurement of harm, according to all the health agencies,  is dependant upon the cotinine level in the body of the nonsmoker, which the CDc reports is between <1 ng (typical) - 15 ng (heavy), then it should stand to reason that if smokers always have levels of cotinine higher than 15 ng, up to 500 ng, we should be long dead even before their current estimates for smokers.
 

The Centers for Disease Control (CDC)
http://www.cdc.gov/nceh/dls/report/Chemicals/cotininegeneral.htm
"Cotinine is a major metabolite of nicotine and is currently regarded as the best biomarker for exposure to tobacco; exposure of both active smokers and of nonsmokers to ETS. Cotinine measurement is preferred over measuring nicotine because, although both are specific for exposure to tobacco, cotinine is retained in the body much longer than nicotine. Cotinine can be measured in blood (i.e., in serum), urine, saliva, and hair. Nonsmokers exposed to typical levels of ETS have cotinine levels less than 1 nanogram per milliliter (ng/mL), with heavy exposure to ETS producing levels in the 1 to 15 ng/mL range. Active smokers almost always have levels higher than 15 ng/mL, sometimes over 500 ng/mL."

 

WE CONTINUE WITH...

Study Finds Even Limited Exposure to Secondhand Smoke
Can Harm Arteries



Let's play a game.  Let's see how many times qualifiers (terms such as "may") appear in each article:
 

Study Finds Even Limited Exposure to Secondhand Smoke Can Harm Arteries

07/24/2001 
Dow Jones Business News 
Associated Press

CHICAGO -- Just half an hour of secondhand smoke can impair normal blood flow to the 
heart, a Japanese study suggests. 

The study examined the effects of spending 30 minutes in a hospital's smoking room on 15 nonsmoking men and 15 smokers. The smokers, whose heart arteries already showed damage, weren't affected. But in nonsmokers, the result was a reduced ability of heart arteries to dilate, which previous research has suggested may be a precursor to hardening of the arteries. 

"This change may be one reason why passive smoking is a risk factor for cardiac disease" and related deaths in nonsmokers, the researchers say in Wednesday's Journal of the American Medical Association. 

The study didn't examine whether the changes from the one-time exposure to smoke were permanent. 

Previous research in smokers has found similar changes that may be reversible if smokers quit, said Dr. David Faxon, president of the American Heart Association. If exposure continues, "gradually, as hardening of the arteries sets in, it's irreversible," he said. 

The study "really sort of confirms prior information that we've had about the adverse effects of secondhand smoke," Dr. Faxon said. 

In the study, Dr. Ryo Otsuka of Osaka City University Medical School and colleagues used blood-pressure tests and an imaging technique called echocardiography to examine the effect on heart arteries' ability to dilate. Measurements were taken before and after exposure to secondhand smoke. 

The smoke appeared to impair the functioning of the endothelium, a lining of cells in the arteries that helps regulate dilation. Scientists believe coronary artery disease may begin when the endothelium becomes damaged, leaving the arteries prone to blockages or narrowing. 

Stanton Glantz, a professor of medicine at the University of California at San Francisco, said the findings add fuel to the debate over secondhand smoke. 

 "People walking into a smoky restaurant, do they want to be clobbering the ability of the 
arteries in the heart to get blood to the heart, even if it's just for a little while?" he said. 

Seth Moskowitz, spokesman for R.J. Reynolds Tobacco Co. (RJR), said the study doesn't 
change the company's belief that there is no scientific evidence establishing that secondhand smoke is a risk factor for lung cancer, heart disease or any other disease in adult nonsmokers. 

Study Finds Evidence of Harmful Effect of Secondhand Smoke on Hearts of Non-Smokers 
 
 

CHICAGO, July 22 (AScribe News) -- Just 30 minutes of exposure to secondhand smoke by healthy non-smokers may have a substantial impact on a function in coronary circulation, according to an article in the July 25 issue of The Journal of the American Medical Association (JAMA). 

Ryo Otsuka, M.D., Hiroyuki Watanabe, M.D., and colleagues from Osaka City University 
Medical School, Osaka, Japan, conducted a study from September 2000 to November
2000 to determine the acute effects of passive smoking on coronary circulation. The study 
included 30 Japanese men who averaged 27 years of age - 15 healthy non-smokers and 15 active smokers without symptoms of disease. None of the men had a history of high blood pressure, diabetes or high cholesterol. 

According to background information cited in the article, passive smoking has been identified as an important risk factor for cardiovascular disease. In 1992, the American Heart Association concluded that the risk of death due to heart disease is increased by about 30 percent among those exposed to environmental tobacco smoke at home, and could be much higher in those exposed at the workplace, where higher levels of environmental tobacco smoke may be present. 

Recent studies have shown that passive smoking may be associated with vascular endothelial dysfunction. However, the acute effects of passive smoking on the coronary circulation in nonsmokers have not been evaluated. 

Normal endothelial cells (cells that line the cavities of the heart and the blood vessels) 
promote vasodilation (an increase in the internal diameter of a blood vessel, causing an increase in blood flow), and inhibit atherosclerosis and thrombosis (formation, development or presence of a blood clot in a blood vessel or the heart). 

Dysfunction of the cells contributes to vasoconstriction (narrowing of blood vessels, 
leading to decreased blood flow), endothelial thrombosis and the process leading to 
development of atherosclerosis. 

The authors used a non-invasive technique called transthoracic Doppler echocardiography to assess coronary flow velocity reserve (CFVR), a measure of endothelial function in the coronary circulation. Echocardiography uses ultrasound waves to make images of the heart chambers, valves and surrounding structures. The authors measured CFVR in each participant before and after a 30-minute exposure to environmental tobacco smoke. 

"Our data revealed that temporary passive smoking abruptly reduced CFVR in 
non-smokers but did not affect CFVR in active smokers. This provides direct evidence of a 
harmful effect of passive smoking on the coronary circulation in non-smokers," the authors write. 

"Mean (average) CFVR in non-smokers was significantly higher than that in active smokers 
before passive smoking exposure (4.4 vs. 3.6, respectively), while CFVR after passive smoking exposure did not differ between groups. Passive smoking exposure significantly reduced mean CFVR in non-smokers (4.4 vs. 3.4, respectively)," they report. 

These substantial changes in endothelial function were not associated with changes in heart rate or blood pressure. 

"The present findings suggest that reduction of CFVR after passive smoking may be caused by endothelial dysfunction of the coronary circulation, an early process of atherosclerosis, and that this change may be one reason why passive smoking is a risk factor for cardiac disease morbidity and mortality in non-smokers," the authors conclude. 

(JAMA. 2001; 286:436-441; available at jama.com) 

 

Discussion:
Article on the left has 5 qualifying terms.  Article on the right has 6 qualifying terms.  The article on the left includes a small statement from Mr. Stanton Glantz, the leading lobbyist of anti-smoking regulations in the U.S. In his statement he takes a literal leap in that all these "mays" magically becomes an absolute that not only might acutely affect you but "CLOBBERS" you.  No one could ever accuse Mr. Glantz of not having a vivid imagination.

He goes on to ask if you're willing to be "clobbered" arterially even if for just a short period.  We wonder if that question still applies if we were discussing the effects of smoke from a campfire, barbeque or romantic fireplace, all of which contain the same chemicals as tobacco smoke.  We suggest that this same test, using the same procedures, be conducted on 30 men who are currently out camping in the woods.  That is, if we actually believed this study concludes anything meaningful, which we don't.

Let's not lose sight of what is meaningful about this study, featured in both of these articles:

"The study didn't examine whether the changes from the one-time exposure to smoke were permanent."

AND
"However, the acute effects of passive smoking on the coronary circulation in nonsmokers have not been evaluated. "

One other reference in the article on the right that we cannot let go without question is:

In 1992, the American Heart Association concluded that the risk of death due to heart disease is increased by about 30 percent among those exposed to environmental tobacco smoke at home, and could be much higher in those exposed at the workplace, where higher levels of environmental tobacco smoke may be present

Other than the anti-smoking mouthpiece, Stanton Glantz, no other reputed health agency endorses this claim.  According to the American Council on Science and Health, this claim is "uncertain and controversial."  The Surgeon General, along with the EPA, has never endorsed this claim in any report on smoking and caution everyone to reserve judgement.

**EDITORIAL**

EVEN A LITTLE SECONDHAND SMOKE IS DANGEROUS
http://jama.ama-assn.org/issues/v286n4/ffull/jed10040.html

  Stanton A. Glantz, PhD; William W. Parmley, MD 
 

As more and more nonsmokers have come to understand the dangers associated with breathing secondhand smoke,1, 2 the number of
communities enacting ordinances requiring smoke-free workplaces and public places has increased rapidly. As of May 2001, hundreds of communities had enacted laws requiring smoke-free workplaces, smoke-free restaurants, and smoke-free bars. California requires all workplaces, including restaurants and bars, to be smoke-free.3, 4 The theme for the World Health Organization's World No Tobacco Day in 2001 was "clean indoor air" and communities throughout the world are beginning to clear the air of secondhand smoke. Not only do the laws protect nonsmokers from the toxins in secondhand smoke, but they also create an environment that helps smokers cut down or stop smoking.5

The tobacco industry's efforts to slow the spread of smoke-free environments has included a systematic effort to attempt to  undermine the scientific evidence that passive smoking causesdisease.6-8 One common theme is that the dose of toxins a nonsmoker inhales is tiny compared with the dose the smoker receives, implying that the risks are trivial or nonexistent. Such statements are based on measuring the delivered dose of 1 or more of the 4000 chemicals in secondhand smoke. The problem with such calculations is they can be manipulated by selecting the particular constituent of smoke to be the one that has low absorption or rapid clearance.1 The real measure of effect should not be the dose of one chemical or another, but rather the biological effect of breathing the
secondhand smoke.

The article by Otsuka and colleagues9 in this issue of THE JOURNAL adds substantially to the case that short-term passive smoking adversely affects endothelial function in ways that immediately compromise the cardiovascular system.10 The investigators demonstrated that, in healthy young volunteers, just 30 minutes of exposure to secondhand smoke compromised the endothelial
function in coronary arteries of nonsmokers in a way that made the endothelial response of nonsmokers indistinguishable from that of habitual smokers.

The investigators measured blood pressure, heart rate, and coronary flow velocity reserve before and after administering adenosine triphosphate using transthoracic Doppler echocardiography of the left anterior descending coronary artery. This innovative noninvasive approach to measuring coronary endothelial function appears to be ideal in these individuals, who have no evidence of coronary disease. Significantly, these substantial changes in endothelial function were not associated with changes in heart rate or blood pressure.

Endothelial dysfunction may be at the heart of the development of atherosclerosis. Normal endothelial cells promote vasodilation and inhibit atherosclerosis and thrombosis, in part because of the release of nitric oxide.11 Dysfunctional cells, on the other hand, contribute to vasoconstriction, atherogenesis, and thrombosis. Risk factors contribute individually to endothelial dysfunction and appear to be additive. One possible unifying hypothesis for the effects of risk factors is that they increase oxidative stress that mediates these
effects.12 Thus, reduction of risk factors improves endothelial function and reduces clinical coronary events. For example, in patients with hyperlipidemia, lipid lowering improves endothelial function both acutely13 and chronically.14

The findings of Otsuka et al9 are important not only because they illustrate the importance of preventing nonsmokers from any exposure to secondhand smoke, but also because they help to explain the relatively large risk of death and other cardiac events associated with passive smoking compared with active smoking. Passive smoking increases the risk of cardiac death or morbidity about 30%15-21 compared with a doubling to quadrupling of risk associated with active smoking. Thus, the effect of passive smoking is as high as one third the effect of active smoking even though the dose of at least some of the constituents is much less than what the smoker inhales.1

The first evidence that nonsmokers were sensitive to a component of tobacco smoke came from studies showing that short-term (30-minute) exposure to secondhand smoke activated nonsmokers' platelets to nearly the extent that they were activated in smokers22, 23 and that passive smoking increased the presence of endothelial cell morbidity in the blood.23 These immediate effects on platelets probably act synergistically with the effects on endothelial function.
The platelet effects convinced epidemiologists that the dose-response curve for cardiovascular effects associated with tobacco smoke exposure was not linear, but exhibited substantial effects at relatively low doses (at least compared with an active smoker; the doses are high when measured against other environmental toxins) that a passive smoker receives.18, 20 In addition, animal studies demonstrated that exposure to the secondhand smoke from a single
cigarette daily induced atherosclerotic changes.24 The fact that passive smoking does not induce additional effects in smokers9, 22 suggests that the underlying biochemical and cellular processes saturate at the doses involuntary smokers experience.

While most people think of cancer when they think of active and passive smoking, it is important to emphasize that heart disease is also an important consequence of tobacco smoke exposure. This situation is particularly true for passive smoking; heart disease accounts for about 37 000 of the estimated 53 000 annual deaths attributed to involuntary smoking in the United States.18 Another important difference between the effects of smoking on risk of cancer
compared with risk of heart disease is that the effects on cancer develop and resolve slowly (over a period of years) whereas the effects of smoking on the cardiovascular system occur rapidly.

The findings of the study by Otsuka et al9 add to the evidence suggesting that everyone should be protected from even short-term exposure to the toxins in secondhand smoke. Communities should continue to require that workplaces, including restaurants and bars, be smoke-free and mount public education campaigns to encourage smoke-free homes. Not only will everyone breathe better,25 but they will also have healthier hearts.
 

Author/Article Information
 

Author Affiliation: Division of Cardiology, Department of Medicine,
University of California, San Francisco. 

Corresponding Author and Reprints: Stanton A. Glantz, PhD,
Division of Cardiology, University of California School of Medicine, 505
Parnassus, Room 1317M, Box 0130, San Francisco, CA 94143-0130
(e-mail: glantz@medicine.ucsf.edu). 

Editorials represent the opinions of the authors and THE JOURNAL
and not those of the American Medical Association.
 
 

REFERENCES

.
                                 1.
                                 US Department of Health and Human Services.
                                 The Health Consequences of Involuntary Smoking: A Report of the
                                 Surgeon General.
                                 Washington, DC: US Dept of Health and Human Services, Public
                                 Health Service, Centers for Disease Control and Prevention;
                                 1986:196-198.

                                 2.
                                 National Cancer Institute.
                                 Health effects of exposure to environmental tobacco smoke: the
                                 report of the California Environmental Protection Agency.
                                 Smoking and Tobacco Control Monograph No. 10. Bethesda, Md: US
                                 Dept of Health and Human Services, National Cancer Institute,
                                 National Institute of Health; 1999. Publication NIH 99-4645. Available
                                at:
                               http://rex.nci.nih.gov/NCI_MONOGRAPHS/MONO10/M10-Ch.7.pdf.
                                 Accessibility verified June 21, 2001.

                                 3.
                                 Glantz SA, Balbach E.
                                 The Tobacco War: Inside the California Battles.
                                 Berkeley: University of California Press; 2000.

                                 4.
                                 Magzamen S, Glantz SA.
                                 The new battleground: California's experience with smoke-free bars.
                                 Am J Public Health.
                                 2001;91:245-252.
                                 MEDLINE

                                 5.
                                 Chapman S, Haddad S, Sindhusake D.
                                 Do work-place smoking bans cause smokers to smoke "harder"?
                                 results from a naturalistic observational study.
                                 Addiction.
                                 1997;92:607-610.
                                MEDLINE

                                 6.
                                 Rennie D.
                                 Smoke and letters.
                                 JAMA.
                                 1993;270:1742-1743.
                                 MEDLINE

                                 7.
                                 Ong E, Glantz S.
                                 Constructing "sound science" and "good epidemiology:" tobacco,
                                 lawyers, and public relation firms.
                                 Am J Public Health.
                                 In press.

                                 8.
                                 Bero L, Barnes DE, Hanauer P, et al.
                                 Lawyer control of the tobacco industry's external research program:
                                 the Brown and Williamson documents.
                                 JAMA.
                                 1995;274:241-247.
                                 MEDLINE

                                 9.
                                 Otsuka R, Watanabe H, Hirata K, et al.
                                 Acute effects of passive smoking on the coronary circulation in
                                 healthy young adults.
                                 JAMA.
                                 2001;286:436-441.
                                 ABSTRACT  |  FULL TEXT  |  PDF  |  MEDLINE

                                 10.
                                 Celermajer D, Adams MR, Clarkson P, et al.
                                 Passive smoking and impaired endothelium-dependent arterial dilation
                                 in healthy young adults.
                                 N Engl J Med.
                                 1996;334:150-154.
                                 MEDLINE

                                 11.
                                 Harrison D.
                                 Cellular and molecular mechanisms of endothelial dysfunction.
                                 J Clin Invest.
                                 1997;100:2153-2157.
                                 MEDLINE

                                 12.
                                 Oskarsson HJ, Heistad DD.
                                 Oxidative stress produced by angiotensin too: implications for
                                 hypertension and vascular injury.
                                 Circulation.
                                 1997;95:557-559.
                                 MEDLINE

                                 13.
                                 Tamai O, Matsuoka H, Itabe H, et al.
                                 Single LDL apheresis improves endothelium-dependent vasodilation in
                                 hypercholesterolemic humans.
                                 Circulation.
                                 1997;95:76-82.
                                 MEDLINE

                                 14.
                                 Treasure CB, Klein JL, Weintraub WS, et al.
                                 Beneficial effects of cholesterol-lowering therapy on the coronary
                                 endothelium in patients with coronary artery disease.
                                 N Engl J Med.
                                 1995;332:481-487.
                                 MEDLINE

                                 15.
                                 Wells AJ.
                                 An estimate of adult mortality from passive smoking.
                                 Environ Int.
                                 1988;14:249-265.

                                 16.
                                 Wells AJ.
                                 Passive smoking as a cause of heart disease.
                                 J Am Coll Cardiol.
                                 1994;24:546-554.
                                 MEDLINE

                                 17.
                                 Wells AJ.
                                 Heart disease from passive smoking in the workplace.
                                 J Am Coll Cardiol.
                                 1998;31:1-9.
                                 MEDLINE

                                 18.
                                 Glantz SA, Parmley WW.
                                 Passive smoking and heart disease: epidemiology, physiology, and
                                 biochemistry.
                                 Circulation.
                                 1991;83:1-12.
                                 MEDLINE

                                 19.
                                 Glantz SA, Parmley WW.
                                 Passive smoking and heart disease: mechanisms and risk.
                                 JAMA.
                                 1995;273:1047-1053.
                                 MEDLINE

                                 20.
                                 Law M, Morris J, Wald N.
                                 Environmental tobacco smoke exposure and ischaemic heart
                                 disease: an evaluation of the evidence.
                                 BMJ.
                                 1997;315:973-980.
                                 MEDLINE

                                 21.
                                 He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK.
                                 Passive smoking and the risk of coronary heart disease: a
                                 meta-analysis of epidemiologic studies.
                                 N Engl J Med.
                                 1999;340:920-926.
                                 MEDLINE

                                 22.
                                 Burghuber O, Punzengruber C, Sinzinger H, Haber P, Silberbauer K.
                                 Platelet sensitivity to prostacyclin in smokers and non-smokers.
                                 Chest.
                                 1986;90:34-38.
                                MEDLINE

                                 23.
                                 Davis JW, Shelton L, Watanabe IS, Arnold J.
                                 Passive smoking affects endothelium and platelets.
                                 Arch Intern Med.
                                 1989;149:386-389.
                                 MEDLINE

                                 24.
                                 Penn A, Chen LC, Snyder CA.
                                 Inhalation of steady-state sidestream smoke from one cigarette
                                 promotes atherosclerotic plaque development.
                                 Circulation.
                                 1994;90:1363-1367.
                                 MEDLINE

                                 25.
                                 Eisner MD, Smith AK, Blanc PD.
                                 Bartenders' respiratory health after establishment of smoke-free bars
                                 and taverns.
                                 JAMA.
                                 1998;280:1909-1914.
                                 MEDLINE
 

Discussion on this article to be followed by the actual study abstract:

Authors use references to substantiate their claims.  When the references are examined and are shown to be worthless or lacking , that makes the paper worthless or lacking.

Mr. Glantz makes 25 references to support his statements.  Of those 25, six of them (#s 3, 4, 7, 8, 18 & 19) are studies or articles from his own hand.  Hey, who better to call on to support yourself but yourself, right?

Reference #2 is to the CAL-EPA report which relied heavily on the 1992 U.S. EPA report.  The U.S. EPA report has been invalidated and vacated by a federal court judge.  That, in turn, wipes out the CAL-EPA report as a reliable source of information.

Reference #5 has a two-fold problem.  Mr. Glantz has no qualms about asserting the fact that smoking bans are a way for him to control individual behavior.  Never doubt that smoking bans are not about protecting health, they are about forcing you to conform to their smoke-free ideology.  He is also depending upon the laziness of readers not to go and read the abstact he is referring to.  The abstract finds that smokers smoke "harder" when taking a smoking break due to indoor bans than when they do in a social setting where they are free to puff at will.  Their conclusion is frightening:  The individual and public health benefits of reduced smoking frequency engendered by work-place smoking bans may be lessened by policies which allow smokers to take smoking breaks.   Read it again.  What they are saying is that by allowing smoking breaks it is undoing the good of reducing how much we smoke because we can't except for breaks.  In other words, they support not even supplying smoking breaks. This reference has nothing to do with the words which precede it in his editorial, "Not only do the laws protect nonsmokers from the toxins in secondhand smoke, but they also create an environment that helps smokers cut down or stop smoking."  Just an example of how you cannot trust Mr. Glantz's true intentions.

References #6 and #8 to support his wholly unscientific standard he employs to explain why the most basic rule of toxicology, "the dose makes the poison," doesn't apply to cigarette smoke is based on the anti-smoking screeching that the tobacco industry lied and manipulated data.  He wants you to believe that measuring chemicals doesn't matter, that it's simply the effect of cigarette smoke on the body that should be taken into consideration and that the tobacco companies mislead you when they discuss the effect of trace chemicals in the body.  To reiterate his statement, "The real measure of effect should not be the dose of one chemical or another, but rather the biological effect of breathing the secondhand smoke."  The scientific community should drum him out of the field for such a ridiculous statement.  You might as well say it doesn't matter how much heat you're exposed to as long as you sweat.  Babies locked in a car on a very hot day will die.  Babies sitting in a covered stroller in the shade on the same day may break a sweat but they'll be fine.  Mr. Glantz also wants to ignore that the Congressional Research Service, who does not answer to the tobacco industry, has upheld the long held scientific standard that indeed, the dose of the chemical and not what is delivering it, is what matters when discussing any effect on the body.  Oh, and oops, he's failed to list in his reference #8 that he was also one of the researchers... Bero L, Barnes DE, Hanauer P, Slade J, Glantz SA.

Reference #10 is a previous study of the effect of cigarette smoke on the arteries of nonsmokers which Mr. Glantz is using to begin the often heard "mountains of evidence."  He doesn't have just one study but at least two.  Well, he can have 100 studies to point to regarding the effect of smoke on nonsmokers but 100 pieces of junk do not make a case.  This referenced study makes no mention of taking any other lifestyle behavior (ie. diet or occupation) into account before deciding that cigarette smoke impairs endothelium-dependent dilatation.

Reference #15, 16 & 17 are all abstracts attributed to an AJ Wells.  That is one person making claims which Mr. Glantz uses to support information in three instances.  There are hundreds if not thousands of researchers yet it appears that relatively few (you can probably count them on one hand) put forth studies, all if not most based on meta-analysis (cherry picking which studies they want to put together to support their preconceived goal), from which Mr. Glantz can rely on to support his arguments.  #15 is not available for review, #16 uses the now invalidated EPA study's procedures to somehow apply that to heart disease which the EPA study did not address and makes a conclusion.  Hello?  #17 also uses meta-analysis to reach it's conclusion.  The EPA does not endorse any claims made about passive smoking and coronary heart disease.  The largest ever cardiology study, MONICA, funded by the World Health Organization, has failed to find a link between heart attacks and the classic risk factors, such as smoking and high cholesterol levels.

Reference #20 & 21 are more of the same.  They show weak statistical evidence that passive smoking is associated with a small increase in the risk of coronary heart disease and are a product of meta-analysis, no original study.  Association should not be confused with causation.  For every one of Mr. Glantz's references that he says supports the risk of heart disease due to passive smoking, we can produce one that does not.  For the most revealing insight as to how studies that Mr. Glantz relies on to support his claim aren't worth much, one need just read an editorial by Dr. John C. Bailar III where he states that nothing has been proven in the risk assessment of passive smoke on the hearts of nonsmokers.

Reference #22 & 23 make some v